Posted inGenetics
The Future of Aging Research Is Longitudinal, Multiomic, and Single-Cell
Sponsored content brought to you by Aging is a complex, lifelong biological process that progressively increases the risk of developing…
Posted inGenetics
Greater Richmond’s Pharma Cluster Keeps Compounding
Sponsored content brought to you by A year after Eli Lilly and Co. put Greater Richmond on the national map…
Posted inBiotechnology
Wiley launches database merging two trusted chemical identification resources
Wiley has released the 2026 edition of the Wiley Registry/NIST Mass Spectral Library, an expanded reference database designed to help…
Posted inBiotechnology
Quantum Crystals Reveal a Mysterious Optical Glow
In a breakthrough that could transform the study of strongly correlated quantum matter, researchers at the University of Basel and…
Posted inBiotechnology
Blood Metabolomic Signatures Link Air Pollution to Lung Cancer in Prevention Studies
A new study is drawing attention to a possible biological pathway connecting polluted air with lung cancer: the chemical changes…
Posted inBiotechnology
DGAT1 Controls Macrophage Pyroptosis During Klebsiella pneumoniae Infection
A new study published in Cell Death Discovery identifies diacylglycerol O-acyltransferase 1, or DGAT1, as an important regulator of macrophage…
Posted inBiotechnology
Epicrispr raises $90M to rewrite treatment of rare muscle disease
Epicrispr Biotechnologies has raised $90 million in a series C round backed by investors including Sanofi Ventures, positioning the biotech…
Posted inBiotechnology
ML Identifies Brain Regions Linked to Impulsivity in Young Adults With Obesity
Obesity may leave a measurable signature in the brain, according to a new large-scale neuroimaging study that uses machine learning…
Posted inBiotechnology
Zydus’ Sentynl pens $475M deal for Mereo’s phase 3-ready rare genetic lung disease drug
Sentynl Therapeutics has penned a deal potentially worth $475 million for the option to market Mereo BioPharma's phase 3-ready rare…
Posted inBiotechnology
After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
With the post-IPO quiet period having come to an end, CEO Benny Sørensen, M.D., Ph.D., was free to sit down…